WHO Pre-Qualification Secured by Kenya-Based Firm as First African Manufacturer of HIV Treatment

In what is being called a transformative turning point for African healthcare, a Nairobi-based pharmaceutical manufacturer has become the first in Africa to produce a World Health Organisation (WHO)–pre‑qualified first-line HIV medicine. The product—TLD, a fixed-dose combination of tenofovir disoproxil…













